SoftWave is a brand of extracorporeal shockwave therapy (ESWT), a treatment that uses acoustic pressure waves to stimulate healing in injured tissue. It has become popular in chiropractic and sports-medicine settings for tendon, joint, and soft-tissue complaints. The underlying science is genuinely interesting, and it is worth separating what is well established from what is still emerging, because the marketing around regenerative therapies often outruns the evidence.
What 'shockwave' actually means
A shockwave is a high-energy acoustic pressure wave, not an electric shock. In medicine, the technology grew out of lithotripsy, the use of focused shockwaves to break up kidney stones. Researchers noticed that the bone and soft tissue near the treatment site responded with increased healing activity, which led to the development of ESWT for musculoskeletal conditions.
Focused versus unfocused, and what SoftWave is
Shockwave devices differ in how they generate and shape the wave. Focused ESWT concentrates energy at a specific depth. SoftWave uses an electrohydraulic spark-gap source that produces an unfocused, broad wave, spreading the energy across a wider treatment area rather than a single deep point. Proponents argue this broad, unfocused profile is well suited to stimulating a larger volume of tissue and the cells within it.
- Electrohydraulic: a spark across a gap in fluid generates the acoustic wave.
- Unfocused: energy spreads across a broad area rather than concentrating at one depth.
- Extracorporeal: generated outside the body and transmitted through the skin.
- Non-invasive: no needles, incisions, or injected substances.
How shockwave is thought to work at the cellular level
The central concept is mechanotransduction, the process by which cells convert a mechanical stimulus into a biochemical response. When the pressure wave passes through tissue, it deforms cell membranes and structures just enough to trigger signaling cascades. Several downstream effects have been described in laboratory and animal studies.
- Angiogenesis: stimulation of new blood-vessel formation, improving local blood supply, associated with upregulation of factors such as VEGF.
- Stem-cell and progenitor activation: recruitment and signaling of resident repair cells in the treated tissue.
- Reduced inflammatory signaling and modulation of pro-inflammatory cytokines over time.
- Increased growth-factor expression that supports tissue remodeling and repair.
- Possible effects on pain signaling at the treated nerve endings.
Extracorporeal shockwave acts through mechanotransduction, converting acoustic energy into biological signals that promote angiogenesis and tissue regeneration.
What the evidence actually supports
Here is where honesty matters. ESWT has a reasonably strong evidence base for several specific musculoskeletal conditions. Focused and radial shockwave are supported by multiple randomized trials and systematic reviews for chronic plantar fasciitis, calcific tendinopathy of the shoulder, and lateral epicondylitis (tennis elbow), and there is growing evidence for Achilles and patellar tendinopathy. For these conditions, shockwave is a legitimate, guideline-discussed option.
The broader regenerative claims, stem-cell activation, cartilage regeneration, and similar, are biologically plausible and supported by laboratory and animal data, but the high-quality human clinical evidence is still early. SoftWave specifically has promising mechanistic and preliminary data, but it does not yet have the large body of randomized human trials that the better-studied indications enjoy. The accurate description is 'early and promising,' not 'proven cure.'
- Well supported: chronic plantar fasciitis, calcific shoulder tendinopathy, tennis elbow.
- Growing support: Achilles and patellar tendinopathy, certain bone-healing applications.
- Early and promising: knee osteoarthritis, broad regenerative and stem-cell claims.
- Not established: shockwave as a treatment for systemic disease.
What to expect from a session
A SoftWave session is non-invasive and typically brief. A gel is applied to the skin and the applicator is moved over the treatment area while it delivers a series of pulses. Most people feel a tapping sensation that can be mildly uncomfortable over sensitive spots but is generally well tolerated. There is no anesthesia and usually no downtime. A course of several sessions is common, since the biological response builds over weeks.
Where it fits at Calloway Chiropractic & Wellness
SoftWave is offered as a tissue-regeneration option alongside the practice's chiropractic care, useful when a soft-tissue or joint problem would benefit from improved local blood flow and a stimulated repair response. Consistent with the practice's overall philosophy, the goal is to support the body's own healing capacity rather than to override it, and the therapy is presented with realistic expectations about what the evidence does and does not yet show.
The bottom line
Shockwave therapy is real medicine with a real mechanism: acoustic energy triggering mechanotransduction, angiogenesis, and a repair response. For several tendon and fascia conditions the evidence is solid. For the broader regenerative promises, the science is genuinely promising but still maturing. An honest practitioner will tell you which is which.